Comparison of Dry needling versus Injection with local anaesthetics in Painful points, known as trigger Points in Myofascial Pain Syndrome in active working population in West Bengal

Comparison of efficacy of Dry needling versus Trigger Point Injection with Bupivacaine and Dexamethasone in Myofascial Pain Syndrome in active working population in West Bengal - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020431

Enrollment

Registered

2019-07-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M791- Myalgia

Interventions

Intervention1: Trigger point injection: TPI will be given with 0.25% Bupivacaine and 4 mg Dexamethasone with 24 G needle once weekly for 4 weeks Control Intervention1: Dry needling: in trigger points

Eligibility

Inclusion criteria

Inclusion criteria: 1) Pain more than 3 months 2) Doesnâ??t relieve with multiple oral medications for last 2 months 4) Intensity of pain more than 4 according to NRS scoring

Exclusion criteria

Exclusion criteria: 1) Local trauma 2) Tumour 3) Inflammation 4) Infection 5) On anticoagulant prophylaxis 6) Blood coagulation disorder 7) Pregnancy 8) Psychiatric illness 9) History of allergy to medication used for the study 10) Uncontrolled Diabetes Mellitus

Design outcomes

Primary

Measure	Time frame
Pain in NRS ScoreTimepoint: before 1st injection and 1 week after the 4th injection.	—

Secondary

Measure	Time frame
NILTimepoint: NA	—

Countries

India

Contacts

Public ContactDr Subrata Goswami

ESI Institute of Pain Management

drsgoswami@gmail.com09830430430

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026